We report a case of combined off-pump coronary artery bypass grafting (OPCAB) and living-donor liver transplantation (LDLT). Patient was admitted to undergo liver transplantation due to Child C cirrhosis secondary to hepatitis B infection, and incidentally, his preoperative cardiac evaluation revealed silent ischemia due to the two-vessel coronary artery disease (CAD). Patient underwent OPCAB followed by LDLT. There was no perioperative cardiovascular event during the days of hospitalization. From the successful anesthetic experience of a combined OPCAB and LDLT, we cautiously suggest that a combined OPCAB and LDLT could be a surgical treatment for the patients with end-stage liver disease (ESLD) and advanced CAD. 
The advancement of surgical techniques together with the change of social prejudice about organ donation has made the liver transplantation expand its indication. As a result, the number of liver transplantation as a surgical treatment of end-stage liver disease is increasing recently. More and more patients can live longer and better life with the help of liver transplantation while postoperative complications and combined cardiovascular risks are challenges to both patients and clinicians. Especially, liver transplantation in the patients with coronary artery disease (CAD) is considered as a very high-risk procedure. Currently, only a limited number of case reports about liver transplantation in the patients with CAD and combined coronary artery bypass grafting (CABG) and living donor liver transplantation (LDLT) are available. In this case, we report a case of combined off-pump coronary artery grafting (OPCAB) and living donor liver transplantation (LDLT) at our hospital.
CASE REPORT
Fifty-six years-old male patient (body weight 60.7-kg, height 167-cm) was admitted for elective LDLT. He suffered from Child-Turcotte-Pugh C cirrhosis secondary to hepatitis B infection. His present illness revealed diabetes mellitus diagnosed one year ago and was well managed with sulfonylurea. He had a three-year history of recurrent hematemesis secondary to esophageal varices and the last variceal ligation was performed one month ago. His model for end-stage liver disease (MELD) score was 23 points from preoperative laboratory data (Table   1) . No active lung disease was identified in his chest X-ray but moderate restrictive lung disease pattern with forced vital capacity 2.03 L (50% of predicted value) was revealed in pulmonary function tests. He had no history of chest pain or dyspnea. His arterial blood gas analysis showed PaO2 58.3 mmHg under room air. He had overly distended abdomen suggesting large amount of ascites. Unexpectedly, his electrocardiography (ECG) revealed anterior infarction and preoperative echocardiography showed left ventricular ejection fraction 50% and regional wall motion abnormalities like thinning of mid to inferior septum and apex of left ventricle in four-chamber view and severe hypokinesia of inferior, anterior, and anteroseptal left ventricular walls in transgastric view in addition to mild ml was re-infused to the patient during OPCAB. The amount of chest tube drainage was 420 ml of bloody fluid, and total urine output was 332 ml averaging about 30 ml/h. Estimated blood loss was 4,500 ml. The laboratory and hemodynamic data as the course of procedures were summarized in Table 2 .
Patient was transferred to intensive care unit postoperatively and was extubated on the next day. Vital signs were all stable without inotropic support and pulmonary artery catheter was removed on the second postoperative day. There were patent vascular and biliary structures in abdominal sonography and no remarkable ECG and echocardiographic changes comparing to preoperative data on fifth postoperative day. Elevated cardiac enzymes immediate postoperative period were normalized on the next postoperative day. Postoperative urine output was maintained at a rate of 100 ml/hr. After eight ICU days, he was transferred to general ward and was discharged on the 54th postoperative day without any cardiovascular complication.
DISCUSSION
Although CAD has been thought to be a contraindication for liver transplantation because high perioperative mortality and can detect regional wall dysfunctions from the dynamic rather than pressure changes [5, 6] . However, TEE monitoring requires experienced hands in addition to the risks of orogastric injury, variceal bleeding, and recurrent laryngeal nerve damage. In this patient, we infused 2 units of fresh frozen plasma before insertion of TEE because preoperative laboratory data showed thrombocytopenia. TEE findings were monitored throughout the operation and very useful information about cardiac functions especially during reperfusion phase could be obtained. Direct visualization of heart function and volume status guided us to manage patient's hemodymics appropriately.
In conclusion, we cautiously suggest that combined OPCAB-LDLT can be a surgical option for the patients with ESLD and high-risk CAD. However, clinical outcomes of the combined procedures are remained yet to be evaluated.
